Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS episode artwork

EPISODE · Oct 23, 2023 · 19 MIN

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

from JAMA Surgery Author Interviews

Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ

Episode metadata supplied by the publisher feed · Published Oct 23, 2023

Embed this episode

Ready to play

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

0:00 19:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Surgery Author Interviews?

This episode is 19 minutes long.

When was this JAMA Surgery Author Interviews episode published?

This episode was published on October 23, 2023.

Can I download this JAMA Surgery Author Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!